← Back
Data updated: Jul 17, 2026
ZEVRA THERAP
Pharma Pharmaceuticals
ZEVRA THERAP is a pharmaceutical company with 1 FDA-approved products.
2018
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
ZEVRA THERAP's Key Drugs
ZEVRA THERAP's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
ZEVRA THERAP's Recent FDA Approvals
New NDA/BLA approvals for ZEVRA THERAP over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
ZEVRA THERAP's Therapeutic Areas
Disease areas where ZEVRA THERAP has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
ZEVRA THERAP Pipeline Snapshot
Active clinical trials for ZEVRA THERAP across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (1)
Company Info
- First Approval
- 2018-02-23
- Latest
- 2024-10-31
- Applications
- 1